John D. Tamerius
2012
In 2012, John D. Tamerius earned a total compensation of $708.5K as SVP, Clinical/Regulatory at Quidel, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $70,803 |
|---|---|
| Option Awards | $227,702 |
| Salary | $292,793 |
| Stock Awards | $24,836 |
| Other | $92,376 |
| Total | $708,510 |
Tamerius received $292.8K in salary, accounting for 41% of the total pay in 2012.
Tamerius also received $70.8K in non-equity incentive plan, $227.7K in option awards, $24.8K in stock awards and $92.4K in other compensation.
Rankings
In 2012, John D. Tamerius' compensation ranked 7,528th out of 11,487 executives tracked by ExecPay. In other words, Tamerius earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,528 out of 11,487 | 35th |
Division Manufacturing | 2,709 out of 4,253 | 36th |
Major group Chemicals And Allied Products | 701 out of 1,198 | 42nd |
Industry group Drugs | 490 out of 920 | 47th |
Industry In Vitro and In Vivo Diagnostic Substances | 25 out of 47 | 47th |
Source: SEC filing on April 1, 2014.
Tamerius' colleagues
We found five more compensation records of executives who worked with John D. Tamerius at Quidel in 2012.